Akademska digitalna zbirka SLovenije - logo
VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives : results of an international, multicentre, case-control study
    Dobert-Ribeiro, Myriam ...
    BACKGROUND: The risk of haemorrhagic stroke associated with use of oral contraceptives (OCs) is less well-established than that for ischaemic stroke. We assessed the risk of haemorrhagic stroke ... associated with current use of modern OCs as now used throughout the world. METHODS: In this WHO collaborative, case-control study, we assessed the association between risk ofhaemorrhagic stroke and use of combined OCs in 1068 cases, aged 20-44 years,and 2910 age-matched controls. We also assessed risks for all strokes combined (haemorrhagic, ischaemic, and unclassified) based on 2198 cases and 6086 controls. FINDINGS: Overall, current use of combined OCs was associated with slightly increased risk of haemorrhagic stroke; the increase was significant in the developing countries (odds ratio 1.76 Š95 percent CI 1.34-2.30Ć) but not in Europe (1.38 Š0.84-2.25Ć). Use of OCs in women younger than 35 years did not affect risk of haemorrhagic stroke in either group of countries, whereas in women aged older than 35 years, odds ratios were greaterthan 2. Women who were current users of OCs and had a history of hypertension (detected before current episode of OC use, but not during pregnancy) had a substantially increased risk (ten-fold to 15-fold) of haemorrhagic stroke compared with women who did not use OCs and had no historyof hypertension. Odds ratios among current OC users who were also current cigarette smokers were greater than 3. In both groups of countries, past use of OCs, dose of oestrogen, and dose and type of progestagen had no effect on risk, and risks were similar for subarachnoid and intracerebral haemorrhage. The odds ratios for any type of stroke associated with current use of low-dose ( less th. 50 micrograms oestrogen) and higher-dose OCs were 1.41 (0.90-2.20) and 2.71 (1.70-4.32), respectively, in Europe and 1.86 (1.49-2.33) and 1.92 (1.48-2.50) in the developing countries.(trunc.)
    Vir: The Lancet. - ISSN 0140-6736 (Letn. 348, št. 9026, 1996, str. 505-510)
    Vrsta gradiva - članek, sestavni del
    Leto - 1996
    Jezik - angleški
    COBISS.SI-ID - 8036057

vir: The Lancet. - ISSN 0140-6736 (Letn. 348, št. 9026, 1996, str. 505-510)
loading ...
loading ...
loading ...

Vnos na polico